Anterix Inc Financials
This page shows Anterix Inc (ATEX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Anterix Inc has an operating margin of -194.2%, meaning the company retains $-194 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -241.5% the prior year.
Anterix Inc's revenue surged 43.9% year-over-year to $6.0M, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Anterix Inc carries a low D/E ratio of 1.13, meaning only $1.13 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 69/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 2.23, Anterix Inc holds $2.23 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 69/100.
While Anterix Inc generated -$29.3M in operating cash flow, capex of $87K consumed most of it, leaving -$29.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Anterix Inc passes 1 of 9 financial strength tests. No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Anterix Inc generates $2.57 in operating cash flow (-$29.3M OCF vs -$11.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Anterix Inc generated $6.0M in revenue in fiscal year 2025. This represents an increase of 43.9% from the prior year.
Anterix Inc's EBITDA was -$11.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 20.3% from the prior year.
Anterix Inc generated -$29.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 170.4% from the prior year.
Anterix Inc reported -$11.4M in net income in fiscal year 2025. This represents a decrease of 24.6% from the prior year.
Anterix Inc earned $-0.61 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 24.5% from the prior year.
Anterix Inc held $47.4M in cash against $0 in long-term debt as of fiscal year 2025.
Anterix Inc had 19M shares outstanding in fiscal year 2025. This represents an increase of 0.9% from the prior year.
Anterix Inc's operating margin was -194.2% in fiscal year 2025, reflecting core business profitability. This is up 47.3 percentage points from the prior year.
Anterix Inc's net profit margin was -188.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 29.2 percentage points from the prior year.
Anterix Inc invested $5.7M in research and development in fiscal year 2025. This represents an increase of 0.7% from the prior year.
Anterix Inc spent $8.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 66.0% from the prior year.
Anterix Inc invested $87K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 71.7% from the prior year.
ATEX Income Statement
| Metric | Q3'26 | Q3'26 | Q2'26 | Q1'26 | Q3'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2K-99.9% | $1.6M+1.4% | $1.6M+9.4% | $1.4M+2.1% | $1.4M-11.3% | $1.6M+1.0% | $1.6M+1.7% | $1.5M |
| Cost of Revenue | N/A | $283K+26.5% | $224K-21.2% | $284K | N/A | $631K-9.7% | $699K-53.1% | $1.5M |
| Gross Profit | N/A | $553K+18.6% | $466K-14.9% | $547K-9.9% | $608K-35.0% | $935K+9.7% | $852K+2266.7% | $36K |
| R&D Expenses | $1K-99.9% | $1.1M-8.9% | $1.2M+8.2% | $1.1M+2.8% | $1.1M-2.8% | $1.1M-36.9% | $1.8M+1.5% | $1.8M |
| SG&A Expenses | $9K-99.9% | $8.7M+3.1% | $8.4M-19.6% | $10.4M+13.3% | $9.2M+0.2% | $9.2M-19.3% | $11.4M-11.3% | $12.9M |
| Operating Income | $9K+100.1% | -$9.1M-114.9% | $60.7M+169.9% | $22.5M+139.3% | $9.4M+33.6% | $7.0M+153.6% | -$13.1M+12.5% | -$15.0M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $2K+100.1% | -$2.1M-127.3% | $7.5M+433.1% | -$2.3M-434.9% | $674K+388.0% | -$234K-201.7% | $230K-81.2% | $1.2M |
| Net Income | $7K+100.1% | -$6.6M-112.3% | $53.5M+112.6% | $25.2M+173.5% | $9.2M+19.4% | $7.7M+160.4% | -$12.8M+17.8% | -$15.5M |
| EPS (Diluted) | $0.35+200.0% | $-0.35-112.2% | $2.86+111.9% | $1.35 | N/A | $0.41+159.4% | $-0.69+17.9% | $-0.84 |
ATEX Balance Sheet
| Metric | Q3'26 | Q3'26 | Q2'26 | Q1'26 | Q3'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $417K-99.9% | $417.0M-0.8% | $420.4M+16.9% | $359.6M+7.9% | $333.1M+2.0% | $326.7M+3.0% | $317.2M-1.2% | $321.1M |
| Current Assets | $50K-99.9% | $50.1M-14.9% | $58.8M+6.2% | $55.4M-8.9% | $60.8M+50.8% | $40.3M-29.1% | $56.8M-13.6% | $65.7M |
| Cash & Equivalents | $30K-99.9% | $29.5M-24.4% | $39.1M-5.7% | $41.4M-12.5% | $47.4M+64.5% | $28.8M-33.2% | $43.1M-16.6% | $51.7M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | $425K | N/A | N/A | $369K+345.1% | $83K-39.0% | $136K-54.2% | $297K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $181K-99.9% | $181.1M+0.6% | $180.0M+3.0% | $174.8M-1.0% | $176.5M-3.0% | $181.9M+2.1% | $178.2M+3.4% | $172.4M |
| Current Liabilities | $36K-99.9% | $36.0M+4.0% | $34.6M-3.7% | $35.9M+32.2% | $27.2M+11.5% | $24.4M+54.4% | $15.8M-4.3% | $16.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $236K-99.9% | $236.0M-1.8% | $240.3M+30.1% | $184.8M+18.0% | $156.6M+8.2% | $144.7M+4.1% | $139.1M-6.5% | $148.8M |
| Retained Earnings | $321K+100.1% | -$320.8M-2.1% | -$314.2M+14.3% | -$366.8M+6.4% | -$391.9M+1.8% | -$399.2M+0.8% | -$402.5M-3.3% | -$389.7M |
ATEX Cash Flow Statement
| Metric | Q3'26 | Q3'26 | Q2'26 | Q1'26 | Q3'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10K+100.1% | -$8.3M-689.2% | $1.4M+144.7% | -$3.1M+81.0% | -$16.6M-115.0% | -$7.7M-190.7% | -$2.6M-12.2% | -$2.4M |
| Capital Expenditures | $9-99.9% | $9K-76.6% | $38K+927.6% | $4K-91.9% | $46K | $0-100.0% | $41K | $0 |
| Free Cash Flow | $10K+100.1% | -$8.3M-311.2% | $3.9M+404.9% | $777K+104.7% | -$16.6M-115.6% | -$7.7M-186.3% | -$2.7M-13.9% | -$2.4M |
| Investing Cash Flow | $6K+100.2% | -$2.3M-281.0% | -$604K+77.3% | -$2.7M-107.5% | $35.4M+2162.6% | -$1.7M+69.0% | -$5.5M-2.7% | -$5.4M |
| Financing Cash Flow | $2K+115.6% | -$10K+98.9% | -$907K-41.3% | -$642K-143.2% | -$264K+94.6% | -$4.9M-1251.7% | -$362K+66.2% | -$1.1M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $990 | $0-100.0% | $990K | $0-100.0% | $2.0M-55.7% | $4.4M | $0-100.0% | $2.0M |
ATEX Financial Ratios
| Metric | Q3'26 | Q3'26 | Q2'26 | Q1'26 | Q3'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | 66.1%-1.4pp | 67.5%+1.7pp | 65.8%-1.1pp | 66.9%+7.2pp | 59.7%+4.8pp | 54.9%+52.6pp | 2.4% |
| Operating Margin | 576.0%+1152.1pp | -576.0%-4485.5pp | 3909.5%+2324.1pp | 1585.4%+908.9pp | 676.5%+227.4pp | 449.0%+1295.6pp | -846.6%+137.8pp | -984.4% |
| Net Margin | 419.6%+839.3pp | -419.6%-3869.1pp | 3449.5%+1673.7pp | 1775.7%+1112.8pp | 662.9%+170.6pp | 492.3%+1315.4pp | -823.1%+194.9pp | -1018.0% |
| Return on Equity | 2.8% | N/A | 22.3%+8.6pp | 13.6%+7.8pp | 5.9%+0.5pp | 5.3% | N/A | N/A |
| Return on Assets | 1.6%+3.2pp | -1.6%-14.3pp | 12.7%+5.7pp | 7.0%+4.2pp | 2.8%+0.4pp | 2.4%+6.4pp | -4.0%+0.8pp | -4.8% |
| Current Ratio | 1.390.0 | 1.39-0.3 | 1.70+0.2 | 1.54-0.7 | 2.23+0.6 | 1.65-1.9 | 3.59-0.4 | 3.98 |
| Debt-to-Equity | 0.770.0 | 0.77+0.0 | 0.75-0.2 | 0.95-0.2 | 1.13-0.1 | 1.26-0.0 | 1.28+0.1 | 1.16 |
| FCF Margin | 635.7%+1162.1pp | -526.5%-1095.2pp | 568.7%+475.3pp | 93.5%+1288.6pp | -1195.2%-703.6pp | -491.6%-318.3pp | -173.4%-18.6pp | -154.8% |
Similar Companies
Frequently Asked Questions
What is Anterix Inc's annual revenue?
Anterix Inc (ATEX) reported $6.0M in total revenue for fiscal year 2025. This represents a 43.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Anterix Inc's revenue growing?
Anterix Inc (ATEX) revenue grew by 43.9% year-over-year, from $4.2M to $6.0M in fiscal year 2025.
Is Anterix Inc profitable?
No, Anterix Inc (ATEX) reported a net income of -$11.4M in fiscal year 2025, with a net profit margin of -188.6%.
What is Anterix Inc's earnings per share (EPS)?
Anterix Inc (ATEX) reported diluted earnings per share of $-0.61 for fiscal year 2025. This represents a -24.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Anterix Inc's EBITDA?
Anterix Inc (ATEX) had EBITDA of -$11.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Anterix Inc's operating margin?
Anterix Inc (ATEX) had an operating margin of -194.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Anterix Inc's net profit margin?
Anterix Inc (ATEX) had a net profit margin of -188.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Anterix Inc's free cash flow?
Anterix Inc (ATEX) generated -$29.4M in free cash flow during fiscal year 2025. This represents a -170.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Anterix Inc's operating cash flow?
Anterix Inc (ATEX) generated -$29.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Anterix Inc's total assets?
Anterix Inc (ATEX) had $333.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Anterix Inc's capital expenditures?
Anterix Inc (ATEX) invested $87K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Anterix Inc spend on research and development?
Anterix Inc (ATEX) invested $5.7M in research and development during fiscal year 2025.
Does Anterix Inc buy back shares?
Yes, Anterix Inc (ATEX) spent $8.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
How many shares does Anterix Inc have outstanding?
Anterix Inc (ATEX) had 19M shares outstanding as of fiscal year 2025.
What is Anterix Inc's current ratio?
Anterix Inc (ATEX) had a current ratio of 2.23 as of fiscal year 2025, which is generally considered healthy.
What is Anterix Inc's debt-to-equity ratio?
Anterix Inc (ATEX) had a debt-to-equity ratio of 1.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Anterix Inc's return on assets (ROA)?
Anterix Inc (ATEX) had a return on assets of -3.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Anterix Inc's cash runway?
Based on fiscal year 2025 data, Anterix Inc (ATEX) had $47.4M in cash against an annual operating cash burn of $29.3M. This gives an estimated cash runway of approximately 19 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Anterix Inc's Piotroski F-Score?
Anterix Inc (ATEX) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Anterix Inc's earnings high quality?
Anterix Inc (ATEX) has an earnings quality ratio of 2.57x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Anterix Inc?
Anterix Inc (ATEX) scores 48 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.